PTAB challenges

Based on the patent's litigation history and the lack of indexed AIA trial proceedings, here is the analysis from the perspective of a senior PTAB practitioner.

Proceedings overview

There are zero AIA trial proceedings (IPR, PGR, or CBM) on file for US patent 5,987,610. For a potential defendant, this means the patent's claims have never been tested at the PTAB, and the primary defensive posture is dictated by its separate federal court litigation history, where key claims were invalidated under 35 U.S.C. § 101.

---

There are no proceedings to report.

Strategic summary

The patent's history presents a clear strategic picture. While the claims are technically UNTESTED at the PTAB, this is overshadowed by their fate in the federal courts.

• Claim Status: The claims of US patent 5,987,610 are untested in any AIA trial proceeding. However, their legal enforceability is effectively nullified by the Federal Circuit's 2016 decision in Intellectual Ventures I LLC v. Symantec Corp., which affirmed the invalidity of the asserted claims under 35 U.S.C. § 101 as being directed to an abstract idea. Any assertion of the same or similar claims would be subject to this binding precedent.

• Estoppel Landscape: Because no IPRs have been filed, there is no petitioner estoppel under 35 U.S.C. § 315(e)(2). A defendant would be free to challenge any surviving or un-asserted claims at the PTAB on any prior-art grounds they choose, as no arguments "reasonably could have been raised" in a prior proceeding.

• Pattern Signals: The most significant signal is the complete absence of PTAB activity for a patent that was heavily litigated by a major patent assertion entity (Intellectual Ventures). This absence is likely explained by the timing and nature of the district court challenges. The defendants in the key litigation chose to pursue a § 101 patent eligibility challenge, a strategy that proved successful and resulted in a broad, definitive invalidation of the asserted claims. A successful § 101 motion is often a faster and more comprehensive "kill shot" than a claim-by-claim prior art challenge at the PTAB. The definitive Federal Circuit ruling likely rendered any subsequent, costly IPR filings unnecessary for other defendants.

Recommended next steps

For any defendant facing an assertion of US patent 5,987,610, the immediate and most powerful response is to leverage the prior Federal Circuit decision.

• Focus on § 101 Invalidation: The primary defensive tool is the Federal Circuit's opinion in Intellectual Ventures I LLC v. Symantec Corp., 838 F.3d 1307 (Fed. Cir. 2016). If the current demand letter cites claims that were subject to that ruling, the assertion has no case. You should explicitly cite this decision in any response to the patent owner. The court held:

  "In sum, we hold that the claims are directed to the abstract idea of filtering content. We further hold that the claims do not contain an 'inventive concept' sufficient to 'transform' the claimed abstract idea into a patent-eligible application."

• No PTAB Action Needed (Initially): Given the existing CAFC precedent, filing an IPR would be a redundant and expensive strategy. The patent's core concept has already been deemed ineligible for patenting by the nation's highest patent court.

• Confirm Asserted Claims: The first step is to demand the patent owner identify exactly which claims are being asserted. If they overlap with those invalidated in the Symantec case, a motion to dismiss citing the Federal Circuit's binding precedent would be the appropriate and most cost-effective next step.

The absence of PTAB activity is a strong signal that the definitive invalidation in federal court was sufficient to neutralize this patent as a significant threat.